69 related articles for article (PubMed ID: 9472646)
1. IR808@MnO nano-near infrared fluorescent dye's diagnostic value for malignant pleural effusion.
Wang X; Yan X; Zhang Z; Xu C; Du F; Xie Y; Yin X; Lei Z; Jiang Y; Yang W; Zhou X; Wang Y
Respir Res; 2024 Jan; 25(1):22. PubMed ID: 38195540
[TBL] [Abstract][Full Text] [Related]
2. Diagnostic and predictive role of cell-free midkine in malignant pleural effusions.
Lv M; Mou Y; Wang P; Chen Y; Wang T; Hou Y
J Cancer Res Clin Oncol; 2013 Apr; 139(4):543-9. PubMed ID: 23212314
[TBL] [Abstract][Full Text] [Related]
3. Detection of CEA and ProGRP Levels in BALF of Patients with Peripheral Lung Cancer and Their Relationship with CT Signs.
Tian K; Li Z; Qin L
Biomed Res Int; 2022; 2022():4119912. PubMed ID: 35937401
[TBL] [Abstract][Full Text] [Related]
4. Association of serum tumor markers with serous effusion in systemic lupus erythematosus.
Zhong Y; Ma J; Zhang L; Liu Z; Xue L
Heliyon; 2023 Dec; 9(12):e23213. PubMed ID: 38144302
[TBL] [Abstract][Full Text] [Related]
5. Exosomes in malignant pleural effusions: Sources and applications.
Huang Y; Wang J; Yao Q; Yang X; Ye X; Liu J; Wang C; Zhou B; Li S; Su B; Mao W; Zhao A
Chin Med J (Engl); 2024 Apr; ():. PubMed ID: 38570199
[No Abstract] [Full Text] [Related]
6. Diagnostic utility of pleural fluid carcinoembryonic antigen in patients with exudative pleural effusion.
Krishnan VG; Kunoor A; Keechilath P; Mehta AA
Lung India; 2021; 38(2):139-143. PubMed ID: 33687007
[TBL] [Abstract][Full Text] [Related]
7. Ratio of carcinoembryonic antigen in pleural fluid and serum for the diagnosis of malignant pleural effusion.
Hackner K; Errhalt P; Handzhiev S
Ther Adv Med Oncol; 2019; 11():1758835919850341. PubMed ID: 31205509
[TBL] [Abstract][Full Text] [Related]
8. Diagnostic utility of serum and pleural fluid carcinoembryonic antigen, and cytokeratin 19 fragments in patients with effusion from nonsmall cell lung cancer.
Sharma SK; Bhat S; Chandel V; Sharma M; Sharma P; Gupta S; Sharma S; Bhat AA
J Carcinog; 2015; 14():7. PubMed ID: 26900349
[TBL] [Abstract][Full Text] [Related]
9. Biomarkers for early detection of malignant mesothelioma: diagnostic and therapeutic application.
Tomasetti M; Santarelli L
Cancers (Basel); 2010 Apr; 2(2):523-48. PubMed ID: 24281081
[TBL] [Abstract][Full Text] [Related]
10. Response to neoplastic pericardial effusion.
Chiara L; Christos L; Witold T; Massimo I; Antonella M; Marzia De B; Agostino S
Clin Cardiol; 2012 Feb; 35(2):131-2. PubMed ID: 22278915
[No Abstract] [Full Text] [Related]
11. Neoplastic pericardial disease: Old and current strategies for diagnosis and management.
Lestuzzi C
World J Cardiol; 2010 Sep; 2(9):270-9. PubMed ID: 21160603
[TBL] [Abstract][Full Text] [Related]
12. Biomarkers for malignant pleural mesothelioma: current status.
Greillier L; Baas P; Welch JJ; Hasan B; Passioukov A
Mol Diagn Ther; 2008; 12(6):375-90. PubMed ID: 19035624
[TBL] [Abstract][Full Text] [Related]
13. Diagnostic utility of pleural fluid carcinoembryonic antigen and CYFRA 21-1 in patients with pleural effusion: a systematic review and meta-analysis.
Gu P; Huang G; Chen Y; Zhu C; Yuan J; Sheng S
J Clin Lab Anal; 2007; 21(6):398-405. PubMed ID: 18022924
[TBL] [Abstract][Full Text] [Related]
14. Serous effusions: diagnosis of malignancy beyond cytomorphology. An analytic review.
Mohanty SK; Dey P
Postgrad Med J; 2003 Oct; 79(936):569-74. PubMed ID: 14612599
[TBL] [Abstract][Full Text] [Related]
15. Evaluation of seven tumour markers in pleural fluid for the diagnosis of malignant effusions.
Miédougé M; Rouzaud P; Salama G; Pujazon MC; Vincent C; Mauduyt MA; Reyre J; Carles P; Serre G
Br J Cancer; 1999 Nov; 81(6):1059-65. PubMed ID: 10576665
[TBL] [Abstract][Full Text] [Related]
16. Evaluation of pleural CYFRA 21-1 and carcinoembryonic antigen in the diagnosis of malignant pleural effusions.
Salama G; Miédougé M; Rouzaud P; Mauduyt MA; Pujazon MC; Vincent C; Carles P; Serre G
Br J Cancer; 1998; 77(3):472-6. PubMed ID: 9472646
[TBL] [Abstract][Full Text] [Related]
17. Use of a panel of tumor markers (carcinoembryonic antigen, cancer antigen 125, carbohydrate antigen 15-3, and cytokeratin 19 fragments) in pleural fluid for the differential diagnosis of benign and malignant effusions.
Porcel JM; Vives M; Esquerda A; Salud A; Pérez B; Rodríguez-Panadero F
Chest; 2004 Dec; 126(6):1757-63. PubMed ID: 15596670
[TBL] [Abstract][Full Text] [Related]
18. Diagnostic value of CYFRA 21-1 tumor marker and CEA in pleural effusion due to mesothelioma.
Paganuzzi M; Onetto M; Marroni P; Filiberti R; Tassara E; Parodi S; Felletti R
Chest; 2001 Apr; 119(4):1138-42. PubMed ID: 11296181
[TBL] [Abstract][Full Text] [Related]
19. Diagnostic utility of CYFRA 21-1, carcinoembryonic antigen, CA 125, neuron specific enolase, and squamous cell antigen level determinations in the serum and pleural fluid of patients with pleural effusions.
Ferrer J; Villarino MA; Encabo G; Felip E; Bermejo B; Vilà S; Orriols R
Cancer; 1999 Oct; 86(8):1488-95. PubMed ID: 10526277
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
